niacinamide has been researched along with Experimental Mammary Neoplasms in 37 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " nicotinamide, isonicotinamide or nicotinic acid, as extra (axial) ligands, were tested in vivo on transplanted mice tumors, namely Lewis lung carcinoma (3LL), melanoma B16, and mammary adenocarcinoma Ca755." | 3.72 | Selectivity of effects of redox-active cobalt(III) complexes on tumor tissue. ( Bubnovskaya, L; Campanella, L; Ganusevich, I; Kovelskaya, A; Levitin, I; Osinsky, S; Sigan, A; Valkovskaya, N; Wardman, P, 2004) |
| "10 mmol/kg) and carbogen breathing, administered alone or in combination, were investigated on two tumour cell lines: EMT6 (a rodent mammary carcinoma) and HRT18 (a human rectal adenocarcinoma) using a clonogenic assay." | 3.69 | Efficacy of agents counteracting hypoxia in fractionated radiation regimes. ( Guichard, M; Stern, S, 1996) |
| "Sorafenib has shown clinical efficacy in treating solid tumours such as renal cell and hepatocellular carcinomas." | 1.38 | Sorafenib in combination with ionizing radiation has a greater anti-tumour activity in a breast cancer model. ( Deblois, F; Devic, S; Heravi, M; Holmes, J; Liang, L; Muanza, T; Radzioch, D; Tomic, N, 2012) |
| " The half-life of nicotinamide increased from 1." | 1.29 | Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations. ( Dennis, MF; Hodgkiss, RJ; Johns, H; Rojas, A; Stratford, MR, 1993) |
| " The elimination half-life and AUC were also found to increase with drug dose, although these increases were non-linear." | 1.29 | Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy. ( Dennis, IF; Honess, DJ; Horsman, MR; Høyer, M; Overgaard, J, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (27.03) | 18.7374 |
| 1990's | 12 (32.43) | 18.2507 |
| 2000's | 7 (18.92) | 29.6817 |
| 2010's | 7 (18.92) | 24.3611 |
| 2020's | 1 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Bazhin, AA | 1 |
| Sinisi, R | 1 |
| De Marchi, U | 1 |
| Hermant, A | 1 |
| Sambiagio, N | 1 |
| Maric, T | 1 |
| Budin, G | 1 |
| Goun, EA | 1 |
| Santidrian, AF | 1 |
| Matsuno-Yagi, A | 1 |
| Ritland, M | 1 |
| Seo, BB | 1 |
| LeBoeuf, SE | 1 |
| Gay, LJ | 1 |
| Yagi, T | 1 |
| Felding-Habermann, B | 1 |
| An, H | 1 |
| Stoops, SL | 1 |
| Deane, NG | 1 |
| Zhu, J | 1 |
| Zi, J | 1 |
| Weaver, C | 1 |
| Waterson, AG | 1 |
| Zijlstra, A | 1 |
| Lindsley, CW | 1 |
| Beauchamp, RD | 1 |
| Wittenborn, TR | 1 |
| Horsman, MR | 11 |
| Mignion, L | 1 |
| Danhier, P | 1 |
| Magat, J | 1 |
| Porporato, PE | 1 |
| Masquelier, J | 1 |
| Gregoire, V | 1 |
| Muccioli, GG | 1 |
| Sonveaux, P | 1 |
| Gallez, B | 1 |
| Jordan, BF | 1 |
| Blazejczyk, A | 1 |
| Switalska, M | 1 |
| Chlopicki, S | 1 |
| Marcinek, A | 1 |
| Gebicki, J | 1 |
| Nowak, M | 1 |
| Nasulewicz-Goldeman, A | 1 |
| Wietrzyk, J | 1 |
| Sabir, A | 1 |
| Schor-Bardach, R | 1 |
| Wilcox, CJ | 1 |
| Rahmanuddin, S | 1 |
| Atkins, MB | 1 |
| Kruskal, JB | 1 |
| Signoretti, S | 1 |
| Raptopoulos, VD | 1 |
| Goldberg, SN | 1 |
| Coxon, A | 1 |
| Bush, T | 1 |
| Saffran, D | 1 |
| Kaufman, S | 1 |
| Belmontes, B | 1 |
| Rex, K | 1 |
| Hughes, P | 1 |
| Caenepeel, S | 1 |
| Rottman, JB | 1 |
| Tasker, A | 1 |
| Patel, V | 1 |
| Kendall, R | 1 |
| Radinsky, R | 1 |
| Polverino, A | 1 |
| Heravi, M | 1 |
| Tomic, N | 1 |
| Liang, L | 1 |
| Devic, S | 1 |
| Holmes, J | 1 |
| Deblois, F | 1 |
| Radzioch, D | 1 |
| Muanza, T | 1 |
| Hammond, E | 1 |
| Brandt, R | 1 |
| Dredge, K | 1 |
| DIETRICH, LS | 2 |
| Overgaard, J | 9 |
| Osinsky, S | 1 |
| Levitin, I | 1 |
| Bubnovskaya, L | 1 |
| Sigan, A | 1 |
| Ganusevich, I | 1 |
| Kovelskaya, A | 1 |
| Valkovskaya, N | 1 |
| Campanella, L | 1 |
| Wardman, P | 1 |
| Rojas, A | 3 |
| Stratford, MR | 2 |
| Bentzen, SM | 1 |
| Denekamp, J | 1 |
| Jonsson, GG | 2 |
| Kjellén, E | 4 |
| Pero, RW | 4 |
| Khalil, AA | 3 |
| Chaplin, DJ | 6 |
| Siemann, DW | 2 |
| Nordsmark, M | 3 |
| Grau, C | 1 |
| Hill, SA | 2 |
| Khalil, A | 1 |
| Hodgkiss, RJ | 1 |
| Dennis, MF | 1 |
| Johns, H | 3 |
| Rojas, AM | 1 |
| Fiat, PR | 1 |
| Høyer, M | 1 |
| Honess, DJ | 1 |
| Dennis, IF | 1 |
| Hirst, DG | 1 |
| Joiner, B | 1 |
| Hirst, VK | 2 |
| Calvert, AS | 1 |
| Stern, S | 1 |
| Guichard, M | 1 |
| Ogawa, A | 1 |
| Griffin, RJ | 1 |
| Song, CW | 1 |
| Braun, RD | 1 |
| Lanzen, JL | 1 |
| Turnage, JA | 1 |
| Rosner, G | 1 |
| Dewhirst, MW | 1 |
| Lorimer, WS | 1 |
| Stone, PR | 1 |
| Kidwell, WR | 1 |
| Kristjansen, PE | 1 |
| Mizuno, M | 1 |
| Christensen, KL | 1 |
| Quistorff, B | 1 |
| Brown, JM | 1 |
| Hansen, PV | 1 |
| Nilsson, P | 2 |
| Cameron, R | 1 |
| Muniz, O | 1 |
| Farinas, B | 1 |
| Franklin, L | 1 |
| von Ardenne, M | 1 |
| Chaplain, RA | 1 |
37 other studies available for niacinamide and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
A bioluminescent probe for longitudinal monitoring of mitochondrial membrane potential.
Topics: Adipocytes; Adipose Tissue, Brown; Aging; Animals; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazon | 2020 |
Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression.
Topics: Acrylamides; Animals; Autophagy; Autophagy-Related Protein 5; Brain Neoplasms; Cell Line, Tumor; Cel | 2013 |
Small molecule/ML327 mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transition.
Topics: Animals; Cadherins; Cell Line, Tumor; Chick Embryo; Colorectal Neoplasms; Epithelial-Mesenchymal Tra | 2015 |
Targeting tumour hypoxia to improve outcome of stereotactic radiotherapy.
Topics: Administration, Inhalation; Animals; Carbon Dioxide; Cell Hypoxia; Diphosphates; Female; Hyperthermi | 2015 |
Non-invasive in vivo imaging of early metabolic tumor response to therapies targeting choline metabolism.
Topics: Animals; Antineoplastic Agents; Choline Kinase; Diffusion Magnetic Resonance Imaging; Female; Hetero | 2016 |
1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis.
Topics: Animals; Cadherins; Cdh1 Proteins; Cell Line, Tumor; Epoprostenol; Female; Gene Expression Regulatio | 2016 |
Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Benzenesulfonates; Female; Mammary Neoplasm | 2008 |
Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cell | 2009 |
Sorafenib in combination with ionizing radiation has a greater anti-tumour activity in a breast cancer model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzenesulfonates; Blotting, Western; Cell Cycle; Cell Di | 2012 |
PG545, a heparan sulfate mimetic, reduces heparanase expression in vivo, blocks spontaneous metastases and enhances overall survival in the 4T1 breast carcinoma model.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoc | 2012 |
AUGMENTATION OF 6-AMINONICOTINAMIDE ANTAGONISM OF TUMOR GROWTH BY COMPOUNDS WITH ESTROGENIC ACTIVITY.
Topics: 6-Aminonicotinamide; Adenocarcinoma; Animals; Antineoplastic Agents; Breast Neoplasms; Cortisone; Di | 1964 |
Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
Topics: Animals; Carbon Dioxide; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Femal | 2004 |
Selectivity of effects of redox-active cobalt(III) complexes on tumor tissue.
Topics: Adenocarcinoma; Animals; Carcinoma, Lewis Lung; Cobalt; DNA Damage; Ethylenediamines; Female; Hypoxi | 2004 |
Is sensitization with nicotinamide and carbogen dependent on nicotinamide concentration at the time of irradiation?
Topics: Animals; Carbon Dioxide; Dose-Response Relationship, Drug; Female; Mammary Neoplasms, Experimental; | 2004 |
Nicotinamide as a radiosensitizer of a C3H mouse mammary adenocarcinoma.
Topics: Adenocarcinoma; Animals; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; NAD; Niaci | 1984 |
The ability of nicotinamide to inhibit the growth of a C3H mouse mammary carcinoma.
Topics: Animals; Antineoplastic Agents; Cell Division; Cyclohexanes; Dose-Response Relationship, Drug; Fatty | 1995 |
The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment.
Topics: Animals; Carbon Dioxide; Combined Modality Therapy; Female; Mammary Neoplasms, Experimental; Mice; M | 1994 |
Reoxygenation in a C3H mouse mammary carcinoma. The importance of chronic rather than acute hypoxia.
Topics: Animals; Carbon Dioxide; Cell Hypoxia; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C | 1995 |
Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.
Topics: Animals; Carbon Dioxide; Cell Hypoxia; Female; Mammary Neoplasms, Experimental; Mice; Niacinamide; O | 1994 |
Tumour radiosensitization by nicotinamide: is it the result of an improvement in tumour oxygenation?
Topics: Animals; Combined Modality Therapy; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; | 1994 |
Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.
Topics: Adenocarcinoma; Animals; Carbon Dioxide; Cell Hypoxia; Cell Survival; Dose-Response Relationship, Dr | 1993 |
Should carbogen and nicotinamide be given throughout the full course of fractionated radiotherapy regimens?
Topics: Adenocarcinoma; Animals; Carbon Dioxide; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C | 1993 |
Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy.
Topics: Adult; Animals; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Male; Mammary Neoplasms | 1993 |
Blood flow modification by nicotinamide and metoclopramide in mouse tumours growing in different sites.
Topics: Animals; Cardiac Output; Colonic Neoplasms; Male; Mammary Neoplasms, Experimental; Metoclopramide; M | 1993 |
Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy.
Topics: Animals; Body Weight; Carbon Dioxide; Dose-Response Relationship, Radiation; Male; Mammary Neoplasms | 1996 |
Efficacy of agents counteracting hypoxia in fractionated radiation regimes.
Topics: Adenocarcinoma; Animals; Carbon Dioxide; Cell Hypoxia; Emulsions; Female; Fluorocarbons; Humans; Hyd | 1996 |
Effect of a combination of mild-temperature hyperthermia and nicotinamide on the radiation response of experimental tumors.
Topics: Animals; Cell Division; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Radiat | 2000 |
Effects of the interaction between carbogen and nicotinamide on R3230 Ac tumor blood flow in Fischer 344 rats.
Topics: Animals; Arterioles; Blood Pressure; Carbon Dioxide; Female; Heart Rate; Mammary Neoplasms, Experime | 2001 |
Control of histone H1 dimer-poly(ADP-ribose) complex formation by poly(ADP-ribose) glycohydrolase.
Topics: Animals; Breast Neoplasms; Cell Line; Cell Nucleus; Female; Glycoside Hydrolases; Histones; Humans; | 1977 |
Biochemical and physiological changes induced by nicotinamide in a C3H mouse mammary carcinoma and CDF1 mice.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Blood Pressure; Fem | 1992 |
Tumor radiosensitization by nicotinamide: a result of improved perfusion and oxygenation.
Topics: Animals; Combined Modality Therapy; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB | 1989 |
Radiosensitization by nicotinamide in tumors and normal tissues: the importance of tissue oxygenation status.
Topics: Animals; Female; Male; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Niacinamide; | 1989 |
Effect of hyperthermia and/or nicotinamide on the radiation response of a C3H mammary carcinoma.
Topics: Animals; Combined Modality Therapy; Female; Hyperthermia, Induced; Male; Mammary Neoplasms, Experime | 1989 |
Comparison of low dose nicotinamide versus benzamide, administered per os, as radiosensitizers in a C3H mammary carcinoma.
Topics: Administration, Oral; Animals; Benzamides; Combined Modality Therapy; Male; Mammary Neoplasms, Exper | 1988 |
Radiosensitization effects of nicotinamide on malignant and normal mouse tissue.
Topics: Animals; Carbon Radioisotopes; Gamma Rays; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB | 1985 |
6-aminonicotinamide-14C utilization by the 755 tumor and host liver tissue.
Topics: Animals; Carbon Isotopes; Mammary Neoplasms, Experimental; Mice; Mitochondria, Liver; Niacinamide; N | 1968 |
The inhibitory effect of B-group vitamins on the incidence of tumour metastases.
Topics: Animals; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasm Metastasis; Niacinamide; Ox | 1971 |